Latest Articles

Publication Date
Dear Doctor: Endometrial cancer is most common North American gynecological cancer - OregonLive.com

Dear Doctor: Endometrial cancer is most common North American gynecological cancer OregonLive.com

Published: May 6, 2026, 1 p.m.
The enzymatic mechanisms of lactylation and its role in gynecological diseases: a comprehensive review.

Lysine lactylation (Kla) is a novel form of post-translational modification. It utilizes lactate as its core substrate. Through an enzymatic regulatory network, it mediates modifications of both histones and non-histone …

Published: April 30, 2026, midnight
Empowering women's health with miRNA-integrated nanochemical approaches: from reproductive health to cancer care.

MicroRNAs (miRNAs), a category of small (18-25 nucleotides) non-coding transcripts that modulate gene expression at the post-transcriptional level, are necessary for regulatory processes in female reproduction, specifically in ovarian function …

Published: April 21, 2026, midnight
GSK’s Phase I ADC trial succeeds in treating advanced gynecological cancers - BioXconomy

GSK’s Phase I ADC trial succeeds in treating advanced gynecological cancers BioXconomy

Published: April 20, 2026, 2:38 p.m.
Novel insights into the role of Annexin A2 signaling pathway in female reproductive system diseases: from mechanisms to advanced therapies.

Annexin A2 (ANXA2) is a calcium-dependent protein with high affinity for phospholipids, and its multifunctional nature has drawn increasing attention in the onset and progression of various disorders of the …

Published: April 14, 2026, midnight
GSK presents positive data for B7-H4-targeted ADC in gynecological cancers - GSK US

GSK presents positive data for B7-H4-targeted ADC in gynecological cancers GSK US

Published: April 12, 2026, 2:25 p.m.
GSK presents positive data for B7-H4-targeted ADC in gynecological cancers - GSK

GSK presents positive data for B7-H4-targeted ADC in gynecological cancers GSK

Published: April 12, 2026, 2:25 p.m.
Strong early data prompts GSK to plan five Phase 3 studies for gynecological cancer ADC - Endpoints News

Strong early data prompts GSK to plan five Phase 3 studies for gynecological cancer ADC Endpoints News

Published: April 12, 2026, 2:10 p.m.
From bench to bedside: unlocking the anti-inflammatory, antioxidant, and anticancer promise of curcumin in gynecology.

Curcumin, a bioactive polyphenol derived from turmeric (Curcuma longa), has garnered substantial attention for its potent anti-inflammatory, antioxidant, and antineoplastic properties. This review explores the therapeutic potential of curcumin in …

Published: Feb. 20, 2026, midnight
Robotic-assisted surgery for gynecological cancers - Penn Medicine

Robotic-assisted surgery for gynecological cancers Penn Medicine

Published: Feb. 10, 2026, 6:30 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!